PR001120 (Project)

Description:Environmental factors, mucosal permeability and defective immunoregulation drive overactive immunity to a subset of resident intestinal bacteria that mediate multiple inflammatory conditions. GUT-103 and GUT-108, live biotherapeutic products rationally designed to complement missing or underrepresented functions in the dysbiotic microbiome of IBD patients, address upstream targets, rather than targeting a single cytokine to block downstream inflammation responses. GUT-103, composed of 17 strains that synergistically provide protective and sustained engraftment in the IBD inflammatory environment, prevented, and treated chronic immune-mediated colitis. Therapeutic application of GUT-108 reversed established colitis in a humanized chronic T cell-mediated mouse model. It decreased pathobionts while expanding resident protective bacteria; produced metabolites promoting mucosal healing and immunoregulatory responses; decreased inflammatory cytokines and Th-1 and Th-17 cells; and induced interleukin-10-producing colonic regulatory cells, and IL-10-independent homeostatic pathways. We propose GUT-108 for treating and preventing relapse for IBD and other inflammatory conditions characterized by unbalanced microbiota and mucosal permeability.
Results found

Linked to

 

Label

Description

 

Project

Metabolomics

Subject

A subject from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project

Biosample

A biosample from Metabolomics produced as part of the PR001120 project


  • Subject

    A subject from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR001120 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.